SUMMARY
INTRODUCTION
Trypanosoma cruzi infects a wide variety of mammalian hosts and in humans can cause life threatening Chagas' disease. In mammals, T. cruzi cycles between intracellular amastigotes and extracellular trypomastigotes and evokes both humoral and cell mediated immune responses. Until recently, anti-T. cruzi antibodies and activated macrophages have been considered the major mechanisms of immune control of this parasite. The lytic (Lages-Silva et al. 1987) , opsonic (Scott & Moyes, 1982) , antibody dependent cellular cytotoxicity (ADCC) (Lima-Martins et al. 1985) , complement activating (Mota and Umekita, 1989 , Brodskyn et al. 1989 , Spinella et al. 1992 ) and invasion blocking (Almeida et al. 1991) activities of antibodies have all been proposed to assist in immune control of T. cruzi. Likewise, activation of macrophage-mediated killing mechanisms by the production of Th1-type cytokines has also been shown to be critical to control of T. cruzi (Gazzinelli et al. 1992 , MunozFernandez et al. 1992 , Metz et al. 1993 , Vespa et al. 1994 . Nevertheless, vaccination studies designed to activate primarily class II MHC-dependent T cell responses and antibody production have consistently failed to provide complete protection in experimental models (Rottenberg et al. 1988 , Ruiz et al. 1986 , Harth et al. 1994 .
In recent years, class I MHC-restricted CD8 þ T cells have been added to the list of critical effectors in immunity to T. cruzi (Nickell et al. 1993) . Support for the importance of CD8 þ T cells in immune control of T. cruzi comes from evidence that depletion of CD8 þ T cells or targeted disruption of genes necessary for the generation of mature CD8 þ T cells results in high susceptibility to T. cruzi in murine models (Tarleton, 1990 , Tarleton et al. 1992 , Rottenberg et al. 1993 , 1995a , Tarleton et al. 1996 . Further, transfer of CD8 þ T cells specific for TSA-1, a target of both murine and human anti-T. cruzi CTL responses, provides significant protection from T. cruzi infection .
In this study we have utilized mice with targeted disruptions in genes controlling B cell development and CD8 þ T cell function to address the question of the relative contribution of these effector mechanisms in control of T. cruzi infection. As predicted from earlier studies, the failure to produce antibodies significantly hinders the generation of a protective response to T. cruzi in either a primary or challenge infection. Surprisingly, however, B cell-deficient mice are able to survive for significantly longer than do mice with defects in either CD4 þ or CD8 þ T cell function. With respect to the effector function of CD8 þ T cells in T. cruzi infection, the high susceptibility of mice with a deficiency in CD8 þ T cells is confirmed in studies using mice lacking TAP-1 gene function. However, infections in mice with induced defects in the cytolytic function of CD8 þ T cells suggest that the control of T. cruzi infection by this population of T cells is not dependent on the granzyme/perforin cytolytic pathway.
MATERIALS AND METHODS

Mice
Wild-type C57Bl/6J mice (common name B6), B cell deficient mice (C57BL/6-Igh-6 tm1Cgn ; common name muMT; (Kitamura et al. 1991) ), beta-2-microglobulin deficient mice (C57BL/6J-B2m tm1Unc ; common name b2m -/-; (Koller et al. 1990) ), perforin deficient (C57BL/6-Pfp tm1Sdz ; common name perforin -/- (Kagi et al. 1994a ) and granzyme B deficient (C57BL/6J-Gzmb tm1Ley ; common name granzyme B -/- (Heusel et al. 1994 )) mice were either obtained from The Jackson Laboratory (Bar Harbor, ME, USA) or were bred in our facility from stocks obtained from The Jackson Laboratory. TAP-1 deficient mice (common name TAP-1 -/-; (Van Kaer et al. 1992) ) on the B6 background were bred from mating pairs obtained from Dr Luc Van Kaer, Vanderbilt University.
Parasites
Blood-form trypomastigotes (BFT) of the T. cruzi Brazil strain were maintained in C3HHe/SnJ mice by biweekly passage and were injected at a dose of 10 3 /mouse by the intraperitoneal (i.p.) route. Trypomastigotes of the T. cruzi M/80 Miranda clone were obtained from culture in bovine embryonic smooth muscle cells and injected i.p. at a dose of 10 6 /mouse. Mice infected with this avirulent M/80 clone were subsequently challenge infected with 5 × 10 4 BFT Brazil strain T. cruzi 294 days later. The parasitaemias in infected mice were determined by weekly examination of tail blood in a haemacytometer and mortality was monitored daily.
Measurements of anti-T. cruzi immune responses
T. cruzi-specific IgM and IgG antibody levels were measured 25 and 35 days post-infection using a previously described procedure (Tarleton et al. 1996) . Measurement of anti-T. cruzi TSA-1 peptide 77.2-specific cytolytic T cell activity was performed as previously described . The percentage specific 51 Cr-release from triplicate wells was calculated as {(average experimental cpm ¹ average spontaneous cpm)/(average maximum cpm ¹ average spontaneous cpm)} × 100. Maximum and spontaneous 51 Cr-release in counts per minute (cpm) were determined from triplicate wells containing labeled target cells only with no effectors in the presence or absence of 5% SDS, respectively.
Histology
Mice were killed by CO 2 inhalation at various times postinfection and tissues from heart, spleen, and skeletal muscle were collected in 10 per cent buffered formalin. The five micron sections of paraffin embedded tissues were fixed, dehydrated and stained with haematoxylin and eosin and examined by light microscopy.
RESULTS
Previous studies have utilized mice with targeted deletions in genes encoding proteins of immunological importance to determine the role of different immune effector mechanisms in immunity to T. cruzi (Tarleton et al. 1992 , Rottenberg et al. 1993 , 1995a , Abrahamsohn and Coffman, 1996 , Santos Lima and Minoprio, 1996 , Tarleton et al. 1996 , Hunter et al. 1997 . To analyse further the mechanism of action of B cells and CD8 þ T cells in T. cruzi infection, we took advantage of mice with an induced mutation in the mu heavy chain immunoglobulin gene and mice with mutations in genes effecting the development and function of CD8 þ T cells. Our initial experiments compared the course of infection with the Brazil strain of T. cruzi in immunocompetent B6 mice, mice lacking b2m gene function, a defect previously shown to result in high susceptibility due to the absence of CD8 þ T cells (Tarleton et al. 1992) , TAP-1 deficient mice which also lack mature CD8 þ T cell function and muMT mice which are defective in immunoglobulin production. As expected, the course of T. cruzi infection in TAP-1 -/-mice closely resembles that of b2m -/-mice with high parasitaemias and death between days 28-33 postinfection (Figure 1 ). In comparison muMT mice infected with same dose of T. cruzi displayed wild-type levels of parasitaemia early in the infection (up to day 28 post infection). However, by 42 days post infection, parasitaemias in the muMT mice had risen significantly above that of wild-type mice and all muMT mice were dead by day 55 post-infection. The absence of antibody production in the muMT mice was confirmed by analysis of serum from infected mice for the presence of anti-T. cruzi IgM and IgG ( Figure 2 ). Thus in the absence of an antibody response, mice infected with T. cruzi exhibit evidence of an initial control of the infection but eventually fail to contain parasite replication and succumb to the infection.
We next asked if the survival of B cell deficient mice could be extended further by initiation of the infection with lower doses of parasites. muMT mice infected with 10 or 100 BFT of the Brazil strain exhibited control of the infection and survival for as long as 89 days post-infection ( Figure 3 ). However, all of these animals did eventually develop high parasitaemia levels and die. Therefore immunoglobulin production is absolutely required for control of an even low initial level infection with a virulent strain of T. cruzi, although defects in other effector populations, in particular CD8 þ ( Figure 1 and Tarleton et al. 1992) and/ or CD4 þ T cells (Rottenberg et al. 1995b , Tarleton et al. 1996 , leads to an even earlier time to death.
The high susceptibility of the TAP-1 -/-mice provides further confirmation of the requirement for the induction of parasite-specific CD8 þ T cells in immunity to T. cruzi . Both cytolytic T lymphocyte (CTL) activity and cytokine production has been documented in anti-T. cruzi CD8 þ T cells ) but the requirement for either or both of these activities in immune control of T. cruzi has not been studied. To begin to address this question, mice with targeted defects in the pathways considered to be the most important in cytolytic killing by CTL were infected with T. cruzi. Perforin-and granzyme B-deficient mice infected with 1000 BFT of the Brazil strain of T. cruzi exhibited parasitaemia levels ( Figure 4 ) and survival rates (100% in all groups in this experiment) comparable to that of wildtype mice. Perforin -/-mice exhibited slightly higher peak blood parasite levels than either B6 or granzyme B -/-mice but parasitaemia levels in all groups were undetectable by day 56 PI and remained so until greater than 100 days postinfection when the experiment was terminated.
Despite the absence of either granzyme B or perforin, spleen cells obtained from these deficient mice at day 90 post-infection displayed significant cytolytic T cell activity versus cells pulsed with peptide 77.2 ( Figure 5 ), a T. cruzi TSA-1-derived peptide which had been previously shown to be a target of anti-T. cruzi CTL . No similar activity was detected against target cells pulsed with an irrelevant peptide (OVA) or incubated without peptide. Both the ability of mice with defects in perforin or granzyme to control T. cruzi infection and the retention of cytolytic activity in splenocytes from these same mice suggest that at least part of the control function of CD8 þ T cells in T. cruzi infection is independent of a granzyme/perforin cytolytic pathway.
The results of histopathological analysis of heart tissues from immunodeficient mice confirm the evidence from parasitaemia and longevity studies indicative of a heightened susceptibility of the TAP-1 -/-and muMT mice and of a relatively unaltered infection in the granzyme B -/-and perforin -/-mice ( Figure 6 ). b2m -/- (Tarleton et al. 1992 (Tarleton et al. , 1996 and TAP-1 -/- (Figure 6a ) mice showed high tissue parasitism both in skeletal muscles (not shown) and heart with negligible inflammation in the acute phase of the infection (day 23). However, muMT mice displayed low levels of tissue parasites and moderate inflammation in heart and skeletal muscles at a comparable time point in the infection (day 25; Figure 6c ), a response very similar to that of the wild-type B6 mice (Figure 6d ). However the tissue parasite burden and inflammation increased in heart muscle of muMT mice and was significantly more intense than that in B6 mice at 45 days post infection (Figures 6e  and 6f, respectively) . Tissue parasitism and inflammation in perforin -/-( Figure 6b ) and granzyme B -/-(not shown) mice at day 45 post-infection was comparable to wild type B6 mice.
The ability of B cell deficient mice to survive for a significant period of time following infection with a virulent strain of T. cruzi suggests that the antibody response is relatively less important, in comparison to the responses mediated by CD4 þ or CD8 þ T cells, in control of the acute infection. This result prompted the question of whether or not protection from infection could be induced by vaccination of animals which lack the ability to generate an antibody response. To address this question immunodeficient mice were infected with a low virulence strain of T. cruzi which had previously been shown to allow for survival in immunodeficient mouse strains (Tarleton et al. 1996) . At approximately 300 days after this primary immunizing infection, the mice were challenged with virulent Brazil strain parasites and the parasitaemia and longevity monitored (Figure 7) . The challenge infection was lethal in all b2m -/-and TAP-1 -/-mice by 32 and 45 days post infection, respectively. B cell deficient mice again exhibited a delay in the rise of parasitaemia and a significant increase in longevity relative to the CD8 þ T cell deficient mice. However these mice eventually died between 60 and 100 days post infection. Granzyme B -/-and perforin -/-mice were protected by the prior infection with avirulent parasites and had no detectable parasites in the blood at any point post-infection with the virulent Brazil strain.
DISCUSSION
Immune control of T. cruzi infection involves multiple immune effector mechanisms (reviewed in Tarleton, 1997) ). Previous studies using cell depletion protocols and/or mice with induced mutations in genes controlling Volume 20, Number 5, May 1998 T. cruzi infection in B cell-and CTL-deficient mice ᭧ 1998 either CD4 þ (Araujo, 1989 , Rottenberg et al. 1993 , 1995a , Tarleton et al. 1996 or CD8
þ (Tarleton, 1990 , Tarleton et al. 1992 , Rottenberg et al. 1993 , 1995a , Tarleton et al. 1996 T cell function have documented the absolute requirement for the activation of both of these T cell subpopulations for survival of mice during the acute phase of T. cruzi infection. Mice with deficiencies in both T cell subsets achieve higher parasite loads and die earlier in the infection than mice with single defects (Tarleton et al. 1996) , indicating a nonoverlapping mechanism of action for CD4 þ and CD8 þ T cells in control of T. cruzi infection. In addition, previous studies also provided strong evidence of an important role for antibodies in regulating T. cruzi in the infected host: anti-m suppressed rats (Rodriguez et al. 1981 ) and mice (Trischmann, 1983 (Trischmann, , 1984 are more susceptible to infection than are immunologically intact hosts.
The present study extends these findings by directly comparing the course of T. cruzi infection in mice lacking either CD8 þ T cells or antibody producing B cells. Mice unable to make antibodies to T. cruzi live substantially longer than mice lacking either CD4 þ (Tarleton et al. 1996) or CD8 þ T cell function, suggesting a more critical role for these T cell populations than for antibody production in the initial control of the infection. Nevertheless, even mice infected with very low numbers of virulent parasites or with an avirulent strain prior to challenge with virulent parasites, are unable to control parasite growth and succumb during the acute parasitaemic phase of the infection. Thus, in agreement with previous studies (Trischmann, 1983 (Trischmann, , 1984 T cells appear to be required for the initial control of the infection but for long-term survival, an effective antibody response is also critical. These results are also consistent with the failure to achieve vaccine-induced immunity with protocols based solely or primarily on induction of antibody responses (Brener 1986 ). Elicitation of antibody production alone is insufficient to control the infection and effective vaccines are likely to additionally require activation of both the CD4 þ and CD8 þ T cell compartments.
The critical effector functions necessary for parasite control by anti-T. cruzi including providing help to B cells and CD8 þ T cells and as activators of effector cells such as macrophages. CD8 þ T cells have been shown to lyse T. cruzi-infected target cells (Nickell et al. 1993 ) and this cytolytic function has been presumed to be the major mechanism of action of these cells. Recently the understanding of the role of CD8 þ T cells in immunity to T. cruzi has been extended with the presentation of information on the protective capacity of parasite-specific CTLs and the identification of antigen targets for some of these anti-T. cruzi CD8 þ T cells. Three members of the trans-sialidase family of surface proteins have now been identified as targets of anti-T. cruzi CTL responses in both mice (Low et al. 1997 and humans (Wizel and Tarleton, in preparation) and short-term CD8 þ T cell lines specific for one of these molecules, TSA-1, have been shown to transfer protection to naive mice ). These T cell lines were highly cytolytic for peptide-pulsed or T. cruziinfected target cells and were potent producers of both IFN-gamma and TNF . The relative contribution of the cytolytic activity or cytokine production of these protective CD8 þ T cells is not known. CD8 þ T cells kill and/or mediate immune control via at least three distinct mechanisms. The perforin/granzyme cytolytic pathway was the first described mechanism of cytolysis by CD8 þ CTL and is still considered the primary cytolytic mechanism in most systems (Atkinson & Bleackley, 1995) . Perforin/granzyme mediated cytolysis involves the release of granules containing perforin, which polymerizes to form pores in the target cell membrane, and granzymes which may enter through these pores and induce apoptosis of the target cell (Berke, 1995 , Kagi et al. 1996b . The generation of knockout mice lacking perforin or granzyme B has allowed investigators to explore the role of this pathway in CD8 þ T cell response in a number of systems (Heusel et al. 1994 , Kagi et al. 1994a , b, Guidotti and Chisari, 1996 , Denkers et al. 1997 , Laochumroonvorapong et al. 1997 , Renggli et al. 1997 , Tang et al. 1997 . In the present work we show that in T. cruzi infection, perforin/ granzyme-mediated cytolysis plays a rather minor role in the protective capacity of CD8 þ T cells. While mice deficient in CD8 þ T cells were highly susceptible to virulent strains of T. cruzi and uniformly die in the acute stage of the infection, mice deficient in either perforin or granzyme B function have little to no increase in susceptibility to primary infection, can be protected by prior infection with an avirulent strain of T. cruzi and continue to exhibit cytolytic activity for host cells displaying T. cruzi peptides. lack of importance of the perforin/granzyme pathway in CD8 þ CTL-mediated killing. In a number of viral systems, particularly cytopathic viruses, killing via the perforin/ granzyme pathway is also a minor factor in protection mediated by CTL (Guidotti et al. 1996 , Kagi et al. 1996b , Kagi & Hensgartner, 1996a . Also early control of infection with either Toxoplasma gondii (Denkers et al. 1997) or Mycobacteria tuberculosis (Laochumroonvorapong et al. 1997) and irradiated sporozoite-induced protection in Plasmodium berghei infection (Renggli et al. 1997 ) are all perforin-independent. CD8 þ CTL may also kill by Fas/Fas-L interactions or via the surface display or secretion of cytokines such as TNF and IFN-gamma (Berke, 1995 , Kagi et al. 1996b . The Fas/ Fas-L pathway of cytolysis has generally been considered to be of primary importance as an immune regulatory pathway (Kagi et al. 1994b , Atkinson et al. 1995 , Griffith et al. 1995 , Kagi et al. 1996b ). However, a number of recent studies have documented a prominent role for Fas/Fas-L interactions in CTL-mediated killing of infected or tumor targets (Kagi et al. 1994b , Lowin et al. 1994 , Clark et al. 1995 , Frost et al. 1997 , Garcia et al. 1997b , Stenger et al. 1997 . Additionally, CTL activity and/or immune control mediated by CD8 þ T cells has been shown in some cases to be independent of both the perforin/granzyme and Fas/Fas-L pathways and has in most of these cases been ascribed to cytokine production, usually TNF and/or IFN-gamma (Guidotti et al. 1996 , Kagi et al. 1996a , Elkon et al. 1997 , Laochumroonvorapong, 1997 , Sutton et al. 1997 . The contribution of these other cytolytic pathways to control of T. cruzi infection are the focus of on-going studies in our laboratory.
T. cruzi infection is not unique with respect to the relative
The retention in perforin and granzyme B deficient mice of cytolytic activity specific for class I MHC-presented T. cruzi peptides suggests that the Fas/Fas-L or cytokine dependent cytolytic mechanisms are involved in the killer activity of T. cruzi-specific CTL. It is also possible that other activities of cytokines, in addition to or rather than cytolysis of target cells, are critical to the protective activity of CD8 þ T cells in T. cruzi infection. The virus inhibitory activity of IFN-gamma and possibly other cytokines are thought to be of greater importance than cytolysis in immunity to cytopathic viruses (Guidotti et al. 1996 , Kagi et al. 1996a , Ando et al. 1997 , Elkon et al. 1997 . Studies in hepatitis B virus transgenic mice (Nakamoto et al. 1997) suggest that in vivo, both lytic (including perforin/granzyme, Fas/Fas-L and TNF dependent) and non-lytic (involving IFN-gamma and TNF production) mechanisms contribute to CD8 þ CTL-mediated target cell destruction. In this latter model it is the nature of the target cells which is proposed to be the primary determinant of the most efficient killing mechanism (Nakamoto et al. 1997) .
Preliminary studies in our laboratory confirm that cytokines produced by T. cruzi-specific CTL can induce nitric Cr release) on peptide-pulsed 5aKb target cells in a six h assay as previously described . 5aKb target cells were either pulsed with 1 mM pep77.2 (open symbols, solid lines) 1 mM ovalbumin peptide SIINFELK (Rotzschke et al. 1991 oxide-dependent regulation of the growth of parasites in non-macrophage cell lines (Rosario & Tarleton, unpublished) . In conjunction with the studies reported in the present study, these finding suggest the following model for immune control in T. cruzi infection. CD4 þ and CD8 þ cells have a primary role in regulation of the infection. CD4 þ T cells likely act through a number of mechanisms, primarily via providing the appropriate helper function for both antibody-producing B cells and CD8 þ CTL. CD4 þ T cells may also serve an important role in the activation of macrophages for killing of intracellular parasites. However in this latter function, the importance of CD4 þ T cells is probably secondary to that of CD8 þ T cells since the majority of the cells infected by T. cruzi in vivo are likely to be non-macrophage, non-MHC class II bearing cells. As reviewed above, the CD8 þ T cells have a variety of mechanisms by which to regulate parasite growth. The cytokines produced by CD8 þ T cells can significantly limit intracellular replication of T. cruzi but appear to be insufficient to completely control the infection. Likewise cytolysis of infected cells by CTL would be expected to result in the premature release, but not necessarily the destruction, of intracellular amastigotes. The role of antibody production as a secondary mechanism of immune control can be explained by the requirement for these antibodies to mediate or potentiate the clearance of released amastigotes. Antibodies may also be important in the killing of trypomastigotes although a considerable body of literature documents the multiple mechanisms by which trypomastigotes of T. cruzi may evade such antibodymediated destruction (De Miranda-Santos and ComposNeto, 1981 , Krettli and Brener, 1982 , Schenkman et al. 1986 , Sher et al. 1986 , Joiner et al. 1988 , Murfin and Kuhn, 1989 , Norris et al. 1989 , Rimoldi et al. 1989 , Hall and Joiner, 1993 , Tomlinson et al. 1994 , Garcia et al. 1997a ). If our model is correct, then efforts toward the production of anti-T. cruzi vaccines should focus on protocols which elicit strong type 1 biased T helper and CTL responses and antibody responses to amastigote-derived molecules. 
